Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan
about
Animal models for Ebola and Marburg virus infectionsReal-time PCR in virologyComparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola AssayEvaluation of RealStar Reverse Transcription–Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and FieldRapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.Diagnosis of Ebola Virus Disease: Past, Present, and FutureEbola Preparedness: Diagnosis Improvement Using Rapid Approaches for Proficiency Testing.Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics PlatformRapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood.Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoproteinOne-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species.Ebola Virus Outbreak Investigation, Sierra Leone, September 28-November 11, 2014.Strategies in Ebola virus disease (EVD) diagnostics at the point of care.Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.Inhibition of filovirus replication by the zinc finger antiviral proteinLaboratory detection and diagnosis of filoviruses.Rapid detection and quantification of Ebola Zaire virus by one-step real-time quantitative reverse transcription-polymerase chain reaction.Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study.Rapid Visual Screening and Programmable Subtype Classification of Ebola Virus Biomarkers.Laboratory diagnosis of Ebola virus disease and corresponding biosafety considerations in the China Ebola Treatment Center.Visual detection of Ebola virus using reverse transcription loop-mediated isothermal amplification combined with nucleic acid strip detection.Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses.An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis of Ebola virus disease.Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.Animal models for filovirus infections.Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.
P2860
Q21131118-4F16581D-D0A5-4570-A3B0-B1ACFA9B64DAQ24514920-91FED619-07D0-4FE9-A6E0-85675F61C219Q26700156-07F528A5-B7F3-42D5-B1ED-E8A4412B3F73Q27468621-5C456569-9DCA-4063-8217-F852F7F0AB2BQ27471311-24733419-7F7A-4350-ADD0-24FFF6BBB0A1Q28388534-9EC1DBFE-4D64-4870-88D6-E200DB2B95E3Q30151521-22146645-184D-42AB-9FC1-AEB76201F0C1Q30151996-05E17AE5-AB94-4D12-96B1-1B2C3ACFB327Q33728729-0DDC8D16-F295-4AE2-9CFB-41132D04E93FQ34512045-08D5534B-5884-45D2-965E-7349111326D2Q34540551-33062C7F-F834-49DF-9738-15A1A44000A0Q35139960-CF0EBEB3-ED18-478A-9F0C-B8FCE235E1C2Q35643774-499C8BB6-29F2-484A-AC78-9ABD97646A46Q36212098-A00B57EE-0631-44E0-BBAA-343230DFC365Q38371191-63397A20-EE24-4F3E-A9D6-D183D4577ACBQ39038799-E0D977B6-FDD9-4141-BF1F-8A14DD4B58B3Q39287976-080E19E8-7E36-4DAC-98BE-AB3FBC8E7079Q39763481-E9377E1E-0D04-496B-B07F-796407AF3E13Q40064193-9649C980-8AF7-4CFD-9778-60F07FD0F9B2Q40074005-DF3AB418-AB5B-4FF3-84C7-8AB80F1938A5Q40076081-FCF20C92-F408-4797-B653-DF9D50F87E9DQ40114945-3E66419D-31A8-4C9C-AAA0-1DDC3300DC83Q40119980-8B523DE3-0BCD-41A0-8293-7A257284E85DQ40254663-6B6CCBFD-7314-4C07-9C7E-56F31F57B957Q42545340-610E973D-5885-4D85-A071-58ED6844F01AQ43684840-9412CA14-B105-4C89-B552-375FAE6F13D1Q51782887-E63161E9-5DB9-40DF-ADB6-F37E46BF2A6DQ54108133-0FA422C1-207A-4DCD-869A-EA18A0A14A01Q54942230-F46B965F-E1BC-4FA7-AF4A-3703399E71D0
P2860
Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development and evaluation of ...... virus subtypes Zaire and Sudan
@ast
Development and evaluation of ...... virus subtypes Zaire and Sudan
@en
type
label
Development and evaluation of ...... virus subtypes Zaire and Sudan
@ast
Development and evaluation of ...... virus subtypes Zaire and Sudan
@en
prefLabel
Development and evaluation of ...... virus subtypes Zaire and Sudan
@ast
Development and evaluation of ...... virus subtypes Zaire and Sudan
@en
P2093
P2860
P1476
Development and evaluation of ...... virus subtypes Zaire and Sudan
@en
P2093
Henchal EA
Norwood DA Jr
P2860
P304
P356
10.1128/JCM.39.11.4125-4130.2001
P407
P577
2001-11-01T00:00:00Z